How to administer KALBITOR?
The recommended dose of KALBITOR is 30 mg (3 mL), administered subcutaneously in three 10 mg (1 mL) injections. If the attack persists, an additional dose of 30 mg may be administered within a 24 hour period.
How do you take ruconest?
Ruconest comes as a single-use vial of powder. The powder is mixed with sterile water to form a liquid solution, which is then given as an intravenous (IV) infusion. This is an injection into a vein that’s given over a period of time. Ruconest infusions are given over the course of about 5 minutes.
What is KALBITOR used for?
KALBITOR is a prescription medicine used to treat sudden attacks of hereditary angioedema (HAE) in people 12 years of age and older. KALBITOR is not a cure for HAE. It is not known if KALBITOR is safe and effective in children under 12 years of age.
How much does kalbitor cost?
The cost for Kalbitor subcutaneous solution (10 mg/mL) is around $15,889 for a supply of 3 milliliters, depending on the pharmacy you visit.
What company makes ecallantide?
Kalbitor (ecallantide) is a medication used to treat hereditary angioedema (HAE) attacks. It is approved by the U.S. Food and Drug Administration (FDA) for use in HAE patients, ages 12 and older. It is manufactured by Shire, a biopharmaceutical company that specializes in rare diseases.
What is the cost of Berinert?
The cost for Berinert intravenous kit 500 intl units is around $3,403 for a supply of 1 kits, depending on the pharmacy you visit….Intravenous Kit.
| Quantity | Per unit | Price |
|---|---|---|
| 1 | $3,402.50 | $3,402.50 |
Who makes Haegarda?
The FDA granted CSL Behring seven years of orphan-drug exclusivity for HAEGARDA, and the Company’s exclusivity for marketing subcutaneous C1-INH to prevent HAE attacks will continue through June 22, 2024. For more information about HAEGARDA, including the U.S. Prescribing Information, visit www.HAEGARDA.com.
What is the brand name for Icatibant?
FIRAZYR® (icatibant injection) is the registered name (also known as the “brand name”) for the treatment that is manufactured by Takeda and was approved by the FDA in 2011. Icatibant is the active ingredient in FIRAZYR.